About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Physical Exercise Augmented CBT for GAD | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNANCT02690441

Physical Exercise Augmented CBT for GAD

Generalised anxiety disorder (GAD) is a severe and debilitating anxiety disorder that is highly prevalent among older adults. Anxiety and GAD is a well-documented risk factor for the development of ot...

Lead sponsor: Solli Distriktspsykiatriske Senter•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Solli Distriktspsykiatriske Senter

Collaborators

University of Bergen
Norwegian University of Science and Technology
University of Oslo
University of California, Berkeley
William Paterson University of New Jersey
Ohio State University

Age

60 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Primary diagnosis of GAD

Exclusion Criteria

•Substance abuse
•Use of benzodiazepines, use of antipsychotica
•Lack of ability to stabilize other psychotropic medication during participating in the study
•Medical condition that precludes participation in physical exercise
•Severe major depression as determined by the MINI International Neuropsychiatric Interview
•Life-time history of psychosis and/or mania
•Participation in other ongoing psychotherapy
•Organic brain disease
•Positive screening for dementia with Mini Mental State Examination
•Currently engaged in a regular physical exercise program

Related studies

LHC-CIDI-5 in Hong Kong

NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more

Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study

NCT07429578 · Generalized Anxiety Disorder (GAD), Chronic Insomnia

Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders

NCT06661460 · ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Specific Phobia, and more

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

NCT05467683 · Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder, and more

RECRUITINGPhase 2

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

NCT06846320 · Generalized Anxiety Disorder (GAD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 22, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment53

Start dateMar 2016

Last updatedSep 22, 2025

Condition

Generalized Anxiety Disorder

Locations shown

Solli DPS

Bergen, Nesttun

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 22, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions